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Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312S70Purpose: Several predictive animal models have been developed for
human osteoarthritis (OA) and used to study the preclinical in vivo
efﬁcacy of disease-modifying OA drugs (DMOADs). In these studies, the
preclinical efﬁcacy has been determined by using various microscopic
scoring systems. Recently, the OARSI histopathology initiative pre-
sented recommendations for histological OA assessment in different
species in order to standardize preclinical efﬁcacy studies. In this study,
we performed a systemic characterization of knee joints in four rat OA
models by using OARSI rat scoring system in association with the
assessment of OA-related joint pain.
Methods: The studywas conducted usingmale Lewis rats. Unilateral OA
was induced in knee joints at 3 months of age by applying the following
rat OA models: 1) intra-articular injection of monoiodoacetate (MIA) at
the dose of 1 mg/kg, 2) medial meniscal tear (MMT) combined with
medial collateral ligament transection (MCLT), 3) anterior cruciate
ligament transection (ACLT) combined with partial medial meniscec-
tomy (pMMx), 4) ACLT. Body weight, static weight bearing determined
as hind paw weight distribution, and static mechanical allodynia
determined as paw withdrawal threshold were followed in each model
during the study. Knee joints were harvested and digital radiographs
were obtained from them at two different time points in each model as
follows: in the MIA model at 2 and 4 weeks, in the MMT + MCLT model
at 3 and 6 weeks, in the ACLT + pMMx model at 4 and 8 weeks, and in
the ACLT model at 5 and 10 weeks. Microscopic assessment of degen-
erative changes was performed in knee joints as recommended by the
OARSI histopathology initiative.
Results: Static weight bearing was decreased in operated knee joints
during the ﬁrst week of the study, demonstrating an operation-related
joint discomfort. Paw withdrawal threshold was decreased in operated
and MIA-injected knee joints during the ﬁrst week and at the end of the
study, indicating operation and OA-related joint pain. Microscopic
assessment of OA demonstrated progressive degenerative changes in
knee joints in all animal models. Mild to moderate changes were
observed in the MIA and ACLT models. In the MIA model, mild degen-
erative changes included the loss of chondrocytes, proteoglycans (PG)
and collagen matrix in superﬁcial layer of articular cartilage in medial
tibial plateau at 2 weeks, and the chondrocyte and PG loss exacerbated
down to intermediate layer at 4weeks. In the ACLTmodel, chondrocytes,
PG and collagen matrix were lost mainly in superﬁcial layer at 5 weeks,
their loss exacerbated down to tidemark at 10weeks, and these changes
were associatedwith the presence of moderate to large osteophytes and
minimal synovial inﬂammation. The MMT + MCLT and ACLT + pMMx
models exhibited moderate to severe degenerative changes. In the
articular cartilage ofmedial tibial plateau, chondrocytes, PG and collagen
matrix were lost from superﬁcial layer down to tidemark in the MMT +
MCLTmodel at 3 and 6weeks, and in the ACLT + pMMxmodel at 4 and 8
weeks. These changes were associated with the presence of large
osteophytes and mild synovial inﬂammation in both models.
Conclusions: This study characterized progressive degenerative
changes as recommended by the OARSI histopathology initiative in
knee joints of four rat OA models used frequently in the preclinical in
vivo efﬁcacy studies of DMOADs. Mild to moderate degenerative
changes were observed in the MIA and ACLT models and moderate to
severe changes in the MMT + MCLT and ACLT + pMMx models. In all OA
models, the development of degenerative changes was associated with
decreased paw withdrawal threshold, indicating OA-related joint pain.
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OLIGOMYCIN, AN INHIBITOR OF COMPLEX V OF MITOCHONDRIAL
RESPIRATORY CHAIN, INDUCES AN INFLAMMATORY RESPONSE IN
RAT KNEE JOINT
C. Vaamonde García, E. López-Peláez, A. Centeno, R. Riveiro-Naveira,
M. Valcárcel-Ares, L. Hermida-Carballo, F. Blanco, M. López-
Armada. INIBIC, A Coruña, Spain
Purpose: A decline of mitochondrial function has been described in OA
chondrocytes and RA synoviocytes. Recent ex vivo ﬁndings support
a connection between mitochondrial dysfunction and activation of
inﬂammatory and destructive pathways in these cells. The aim of this
study was to investigate in vivo articular model if the intraarticular
injection of oligomycin, an inhibitor of mitochondrial function, induces
a destructive and inﬂammatory response in rat knee joints.
Methods: 24 female wistar rats (180-220g) was divided into three study
groups: Healthy (no intraarticular injection); Lipopolysaccharide (LPS)-
treated, positive control (left joint injected with: LPS 10ug and rightjoint with vehicle); and Oligomycin (OLI)-treated (left joint injected
with Oligomycin 20ug and right joint with vehicle). Three intraarticular
injections were carried out at days 0, 2 and 5. Rats were sacriﬁced at day
6, hind paws were collected and joint tissues were obtained.
Measurement of joint diameters on stimulis- and control-injected paws
was performed at days 0 and 6. Histopathologic lesions were evaluated
by hematoxilyn-eosin (H&E) and masson trichromic stain sections in
synovial tissue and by safranin O staining in cartilage. By RT-PCR, CINC-
1, IL-1b, CCL-2 and TNF-a gene expression were analyzed in extracted
cartilage. And by immunohistochemical staining, IL-8, equivalent of
CINC-1, expression was localized in the joint tissue.
Results: OLI-treated hind paws signiﬁcantly increased the joint diam-
eter (0.90.1 mm, n¼8, p<0.05, vs vehicle-injected joints), similarly to
LPS-treated (20.3 mm, n¼8, p<0.05, vs vehicle-injected joints). In
relation, histological evaluation of synovial tissue by H&E staining
revealed that joints treated with mitochondrial inhibitor present
greater synovial lining hyperplasia, proliferation of subsynovial tissue
and inﬁltration of a marked number of inﬂammatory cells while the
right control synovial only contained a moderate synovial proliferation
and inﬂammation (3.30.1 vs. 2.10.2, respectively, n¼8, p<0.001, vs
vehicle-injected joints). Besides, immunohistochemical studies on IL-8
showed a greater expression in synovial tissue from OLI-injected joints
versus those from vehicle-injected joints, coinciding with a strong
neutrophils inﬁltration. In relation to cartilage, when the loss of matrix
in the cartilage by safranin O stainingwas evaluated no differences were
observed, neither when IL-8 immunoperoxidase staining was per-
formed in cartilage. By contrast, when CINC-1 mRNA was analyzed in
this tissue, it was detected a signiﬁcant increment in OLI-injected joint
(n¼8, p<0.05 vs. vehicle-injected joint), similarly to LPS-treated.
Conclusions: The data seems to support that a loss of mitochondrial
function in the joint could participate in rheumatoid pathology through
generating an inﬂammatory response in the articular tissue, contrib-
uting to the perpetuation of joint injury.
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EXPRESSION OF PPAR A, B, G, AND H-AND L-PGDS DURING
OSTEOARTHRITIS IN THE SPONTANEOUS HARTLEY GUINEA PIG
AND THE EXPERIMENTAL DOG MODELS
S.-S. Nebbaki y, F.E.L Mansouri y, H. Aﬁf y, M. Kapoor y, M. Mohamed
Benderdour z, J.-P. Pelletier y, J. Martel-Pelletier y, H. Fahmi y. yCR-
CHUM, Notre Dame Hosp., Montreal, QC, Canada; zCR-CHUM, Hôpital
Sacré-Coeur de Montréal, Montreal, QC, Canada
Purpose: To investigate the expression of peroxisome proliferator-
activated receptor (PPAR) a, b, g, and hematopoietic and lipocaline-type
prostaglandin D synthase (H- and L-PGDS) over the course of osteoar-
thritis (OA) in the spontaneous Hartely guinea pig and the anterior
cruciate ligament transection dog models.
Methods:Guinea pigswere sacriﬁced at 2 (control group), 4, 8, and 12 (n
¼ 5 per group)months of age. Non-operated (control) and operated dogs
were sacriﬁed at 4, 8 and 12weeks post-surgery. Cartilagewas evaluated
histologically using the Osteoarthritis Research Society International
(OARSI) guidelines. The expression of PPARa, b, g, and H- and L-PGDS
were evaluated by real-time PCR and immunohistochemistry. The non-
parametric Spearman test was used for correlation analysis.
Results: PPARa, b and g were detected in medial tibial plateau from
control animals in both the spontaneous and surgical models. The levels
of PPARa and b did not change over the course of OA, whereas PPARg
levels decreased during the progression of the disease. We also showed
that the expression of H-PGDS remained unchanged, whereas that of L-
PGDS increased over the course of OA. PPARg levels correlated nega-
tively, whereas L-PGDS levels correlated positively, with the histological
score of OA.
Conclusion: The level of PPARg decreased, whereas that of L-PGDS
increased during the progression of OA. These data suggest that reduced
expression of PPARg may contribute to the pathogenesis of OA, whereas
enhanced expression of L-PGDS may be part of a reparative process.115
INITIATIONANDPROGRESSIONOFOCHRONOTICOSTEOARTHROPATHY
IN ALKAPTONURIC MICE
C.M. Keenan, A.J. Preston, H. Sutherland, A.M. Taylor, P.J. Wilson,
D. Williams, L.R. Ranganath, J.A. Gallagher, J.C. Jarvis. Univ. of
Liverpool, Liverpool, United Kingdom
Abstracts / Osteoarthritis and Cartilage 21 (2013) S63–S312 S71Purpose: Alkaptonuria (AKU) is an ultra rare autosomal recessive
disorder resulting from a deﬁciency of the enzyme homogentisate 1, 2-
dioxygenase (Hgd), and is characterised by accumulation of homoge-
ntisic acid (HGA) in plasma and marked excretion in urine. HGA is
deposited as a dark pigment in collagenous tissues (ochronosis), prin-
cipally the cartilages of loaded joints, resulting in early onset, devas-
tating osteoarthropathy. Studying the extreme AKU phenotype is
helping to increase our understanding of more common osteoarthritis
(OA). Previous studies have suggested that Hgd-/- mice do not develop
ochronosis. Our aim was to make a comprehensive survey of Hgd-/-
mice, to identify if ochronosis was present, and to determine the
pathogenesis.
Methods: Hgd-/- mice were culled between 6 and 65 weeks and
samples wax-embedded in the coronal plane to enable simultaneous
evaluation of both medial and lateral tibio-femoral articulations, as
recommended by the OARSI histopathology initiative. Histological
evaluation was performed with Schmorl's reagent and haematoxylin-
eosin staining.
Results: We report the ﬁrst observation of ochronosis in Hgd-/- mice.
Using Schmorl's reagent we identiﬁed the earliest stages of ochronosis
and were able to follow the pathogenesis of the disease throughout
their lifespan. Pigmentation was initially identiﬁed at 16 weeks, local-
ised to the pericellular matrix of individual chondrocytes in calciﬁed
articular cartilage. Pigmentation was then observed progressing to the
cellular compartment of an increasing number of chondrocytes
throughout the calciﬁed articular cartilage by age 40 weeks. After 65
weeks, pigmentation of chondrocytes and their pericellular matrix was
observed throughout the calciﬁed articular cartilage of the entire tibio-
femoral joint. Although pigmentation was extensive at this stage, some
viable chondrocytes remained as well as those still in the early phases of
pigmentation. In some instances both viable and pyknotic chondrocytes
were observed in the same isogenous group.Figure 1. Progression of ochronosis in Hgd-/- mice. Stages of pigmentation show (1)
a viable unstained chondrocyte, (2) pericellular pigmentation and (3) a fully pig-
mented pyknotic chondrocyte. Bar ¼ 20mm.Conclusions: The observation of ochronosis in Hgd-/- mice is an
important step in understanding the pathogenesis of AKU. By identifying
the earliest stage of ochronosis, which is synonymous to that seen in
human AKU, we can investigate the initiation and progression of
pigmentation. Initial pigmentation in the pericellular matrix suggests
a compositional or organisational change occurs in the matrix allowing
deposition of HGA, which binds to collagen ﬁbres starting the process of
ochronosis. Progression of ochronosis to the cell is consistent with
ochronosis in humans, and is probably due to the increasing amount of
HGA being deposited following the initial transformation of its peri-
cellular environment. The very early ochronosis and subsequent
progression observed in this study shows that AKU, thoughpresenting in
humans as a painful syndrome in mid-life, is the result of a lifelong
pathological process. Using Hgd-/- mice, we can now investigate
biochemical andpathological changes associatedwithAKU that progressto joint degeneration. Furthermore, as AKU is associated with the onset
of prematureOA,we canuse themodel to identify the initiating events in
OA by studying the role of subchondral bone and calciﬁed cartilage: both
play an important role in the pathology of AKU and OA.
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MOLECULAR PREDICTORS OF HAND STRENGTH
D. Thompson, K. Huffman, G. McDaniel, J. Bain, R. Stevens,
C. Newgard, V. Kraus. Duke Univ., Durham, NC, USA
Purpose Grip strength predicts disability and mortality, yet few
biomarkers of hand strength have been identiﬁed. We surveyed a wide
array of serum cytokines, metabolites and joint tissue markers to
identify novel independent predictors of grip and pinch strength.
Methods Subjects were originally recruited for a longitudinal study of
radiographic knee osteoarthritis (OA) progression. At three year follow
up, measurement of grip strength (Jamar Hydraulic Hand Dynamom-
eter) and key pinch strength (Jamar Hydraulic Pinch Gauge) were per-
formed twice on each hand, and the greatest value was used for
analyses. To control for hand OA, bony enlargements of the four distal
and ﬁve proximal interphalangeal joints, the ﬁve metacarpophalangeal
joints, and the carpometacarpal joint were summed (range 0-15) for the
stronger hand. Blood (2 hour postprandial) was collected, and serum
stored at -80oC. Cytokines and inﬂammatory markers (adiponectin;
brain-derived neurotrophic factor; d dimer; granulocyte colony stim-
ulating factor; interleukins 1, 6, and 8; regulated upon activation normal
T cell expressed and secreted; tumor necrosis factor alpha, TNFa; TNFa
receptors 1 and 2; TNF related apoptosis-inducing ligand, TRAIL; soluble
vascular cell adhesion molecule 1; and vascular endothelial growth
factor) and joint tissue markers (C2C; CPII; cartilage oligomeric matrix
protein; hyaluronic acid, HA; and matrix metalloproteinase 3) were
measured by immunoassay. Acylcarnitines (ACs, n¼45) and amino acids
(AAs, n¼15) were measured using a targeted mass-spectrometry plat-
form. Additional metabolites (glucose; a-hydroxybutyrate; total
ketones; lactate; non-esteriﬁed fatty acids; and uric acid) were
measured with a Hitachi 911 analyzer. Computed variables included
global arginine bio-availability ratio (GABR, arginine/(ornithine +
citrulline) and C2C:CPII. All variables except age, HA, MCP-1, and TRAIL
were log-transformed because of non-normal distributions. Principal
components analysis, with varimax rotation, reduced separately the
AAs and ACs each to a 1 factor solution. Multivariable correlations were
performed between grip or pinch strength and serum markers,
controlling for age, sex, and height. Candidate predictors of grip or
pinch strength were analyzed by linear regression, controlling for age,
sex, height and sum of bony enlargements followed by multivariable
modeling of signiﬁcant variables by stepwise selection (p<0.05).
Results The subject population (n¼138) was 73% female, mean (SD) age
of 65.8 (11.5) years, BMI 31.4(6.9) kg/m2, grip strength of 27.4 (10.0) kg,
and pinch strength of 5.9 (1.9) kg. Grip and pinch strength correlated
with age, sex, and height (p<0.05), but not weight, BMI, or sum of bony
enlargements. Multivariable modeling identiﬁed sex, age, height, C2C,
and the AA Factor as signiﬁcant, independent predictors of grip
strength; the model predicted 55% of the variability of grip strength and
was signiﬁcant at p<0.0001. For pinch strength, multivariable modeling
identiﬁed sex, age, height, the ratio C2C:CPII, GABR, and the AC Factor as
signiﬁcant, independent predictors; the model predicted 49% of the
variability of pinch strength and was signiﬁcant at p<0.0001.
Conclusion This exploratory analysis identiﬁed several novel, inde-
pendent predictors of both grip and pinch strength. As seen previously,
age, sex, and height were the strongest predictors of hand strength. AA
factor predicted grip strength, perhaps reﬂecting sarcopenia status. The
association of C2C or the ratio of C2C and CPII, markers of collagen
breakdown and synthesis, respectively, with grip and pinch strength
suggests the involvement of joint tissue turnover with hand function.
The signiﬁcant associations of GABR and the AC factor implicate
metabolic pathways in pinch strength.
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